ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Skeeter Bug who wrote (2)	9/23/1997 11:29:00 AM
From: pat w.	of 1084

RESEARCH ALERT - Aastrom (NASDAQ:ASTM) started as buy Reuters, Tuesday, September 23, 1997 at 10:43 NEW YORK, Sept 23 (Reuter) - J.P. Morgan Securities said analyst Craig Parker initiated coverage of Aastrom Biosciences Inc with a buy rating and a 12-month price target of $12. -- called company "a leader in automation technology for cell therapy." -- the stock was up 3/8 to 4-1/2. Copyright 1997, Reuters News Service Companies or Securities discussed in this article: SymbolName

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next